CRSP — CRISPR THERAPEUTICS AG
As of Q2 2026, 33 SEC-registered investment managers reported holding CRSP (CRISPR THERAPEUTICS AG) in their latest 13F filings, with a combined reported value of $2.13B across 39.23M shares. That is +2.1% by share count (+822.59K shares) versus the previous quarter, while reported value moved +17.1%. Ownership is concentrated: the five largest holders account for 69.2% of reported value and the top ten for 85.7%.
Compared with the prior quarter, 1 opened new positions, 18 added to existing stakes, 12 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
CRSP is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| ARK Invest history | Q2 2026 | 9.46M | $516.00M | 3.35% | Reduce |
| BlackRock Inc history | Q2 2026 | 8.35M | $455.35M | 0.01% | Add |
| Capital World Investors history | Q2 2026 | 4.75M | $259.04M | 0.03% | Add |
| Geode Capital Management history | Q2 2026 | 2.51M | $136.92M | 0.01% | Add |
| Vanguard Group history | Q4 2025 | 2.27M | $118.95M | 0.00% | Reduce |
| Two Sigma Investments history | Q2 2026 | 1.99M | $108.46M | 0.08% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 1.91M | $104.09M | 0.01% | Reduce |
| UBS Group AG history | Q2 2026 | 1.32M | $71.99M | 0.01% | Reduce |
| Bank of America Corp history | Q2 2026 | 1.16M | $63.00M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 1.06M | $57.69M | 0.01% | Add |
| Citadel Advisors history | Q2 2026 | 1.01M | $55.20M | 0.01% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 1.01M | $54.98M | 0.03% | Add |
| Morgan Stanley history | Q2 2026 | 879.95K | $47.99M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 863.09K | $47.07M | 0.01% | Add |
| Farallon Capital Management history | Q2 2024 | 530.00K | $28.63M | 0.14% | New |
| JPMorgan Chase & Co history | Q2 2026 | 431.67K | $24.57M | 0.00% | New |
| Millennium Management history | Q2 2026 | 439.73K | $23.98M | 0.01% | Add |
| Casdin Capital history | Q4 2021 | 266.43K | $20.19M | 0.57% | Hold |
| BNY Mellon history | Q2 2026 | 326.76K | $17.82M | 0.00% | Add |
| Baillie Gifford & Co history | Q3 2024 | 364.77K | $17.14M | 0.01% | Reduce |
New Positions (Q2 2026)
- JPMorgan Chase & Co 431.67K sh · $24.57M
Fully Exited (vs previous quarter)
- Janus Henderson Group sold 40.27K sh · $1.92M
- Amundi US sold 8.26K sh · $393.02K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ARK Invest | 7.59M | 9.09M | 9.41M | 9.73M | 8.24M | 7.83M | 7.99M | 7.34M | 7.16M | 8.54M | 8.16M | 7.78M | 7.50M | 8.97M | 10.17M | 10.18M | 9.79M | 10.52M | 11.31M | 9.46M |
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | — | — | 2.80M | 2.76M | 2.61M | 6.07M | 7.05M | 7.51M | 7.68M | 8.35M |
| Capital World Investors | — | 421.49K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 4.73M | 4.75M |
| Geode Capital Management | 64.45K | 66.27K | 663.09K | 714.20K | 764.68K | 789.10K | 809.98K | 834.61K | 849.94K | 883.73K | 909.30K | 973.02K | 1.01M | 1.00M | 1.05M | 2.07M | 2.14M | 2.25M | 2.38M | 2.51M |
| Two Sigma Investments | 5.27K | 212.58K | 318.37K | 45.42K | 112.09K | 41.73K | 216.03K | 433.07K | 219.79K | 85.03K | 49.06K | 17.06K | 179.05K | 306.27K | 1.19M | 1.55M | 1.04M | 470.62K | 1.48M | 1.99M |
| Fidelity Management & Research (FMR) | 574.48K | 370.72K | 1.26M | 1.62M | 2.15M | 2.18M | 2.14M | 2.09M | 2.06M | 1.84M | 2.24M | 2.35M | 2.38M | 2.22M | 1.94M | 1.93M | 1.89M | 1.95M | 1.95M | 1.91M |
| UBS Group AG | 139.65K | 189.89K | 203.43K | 233.92K | 267.96K | 448.54K | 263.65K | 281.46K | 355.93K | 384.93K | 359.46K | 461.12K | 693.90K | 2.00M | 2.08M | 2.86M | 2.42M | 2.52M | 1.76M | 1.32M |
| Bank of America Corp | 1.50M | 734.61K | 726.05K | 1.71M | 2.15M | 426.52K | 517.71K | 768.16K | 679.70K | 860.07K | 1.03M | 1.06M | 1.08M | 1.21M | 1.39M | 1.70M | 1.29M | 1.10M | 983.07K | 1.16M |
| Charles Schwab Investment Management | — | — | 354.80K | 348.12K | 622.12K | 641.09K | 640.78K | 646.71K | 637.94K | 653.02K | 669.19K | 717.61K | 724.24K | 723.03K | 713.54K | 933.20K | 985.77K | 1.03M | 1.04M | 1.06M |
| Citadel Advisors | 982.72K | 999.22K | 1.16M | 1.40M | 1.12M | 1.05M | 621.24K | 835.66K | 803.15K | 2.12M | 1.56M | 1.22M | 1.49M | 1.96M | 1.10M | 1.29M | 1.91M | 1.60M | 1.35M | 1.01M |
| D. E. Shaw & Co | 98.70K | 163.07K | 235.52K | 205.90K | 175.90K | 262.30K | 145.10K | 102.50K | 102.50K | 284.47K | 405.89K | 106.27K | 124.17K | 74.90K | 51.40K | 133.60K | 430.50K | 411.30K | 142.70K | 1.01M |
| Morgan Stanley | 580.02K | 543.51K | 517.39K | 567.46K | 585.84K | 507.79K | 470.53K | 390.84K | 351.44K | 413.08K | 1.09M | 597.68K | 632.00K | 495.00K | 1.30M | 511.38K | 1.40M | 667.06K | 668.14K | 879.95K |
| Northern Trust Corp | 42.30K | 43.31K | 165.61K | 184.23K | 198.76K | 188.64K | 198.87K | 239.16K | 244.25K | 250.43K | 243.28K | 233.41K | 227.75K | 257.17K | 237.65K | 761.12K | 779.93K | 755.11K | 802.18K | 863.09K |
| JPMorgan Chase & Co | 644.59K | 771.90K | 13.50K | 13.50K | 13.50K | 13.50K | 538.91K | 551.39K | 520.43K | 200.00K | 26.00K | 400 | 400 | 400 | 295.99K | 10.30K | 593.42K | 53.20K | — | 431.67K |
| Millennium Management | 221.70K | 413.37K | 67.19K | 20.00K | 9.61K | 12.14K | 259.98K | 112.75K | 136.23K | 17.27K | 108.74K | 26.33K | 143.09K | 8.50K | 583.73K | 70.09K | 86.28K | 30.49K | 377.18K | 439.73K |
| BNY Mellon | 62.07K | 64.70K | 91.06K | 101.78K | 118.44K | 108.91K | 108.86K | 108.08K | 105.42K | 107.89K | 75.31K | 78.69K | 75.02K | 76.57K | 77.70K | 301.96K | 304.61K | 310.95K | 311.38K | 326.76K |
| Goldman Sachs Group | 328.08K | 234.19K | 116.60K | 638.71K | 1.07M | 663.93K | 308.45K | 208.49K | 195.04K | 216.72K | 140.20K | 265.35K | 209.84K | 197.27K | 147.33K | 243.90K | 256.84K | 275.63K | 414.22K | 272.37K |
| Norges Bank Investment Management | — | — | — | — | — | 715.43K | — | — | — | 617.59K | — | 650.21K | — | 443.54K | — | 406.49K | — | 490.21K | — | 270.76K |
| Wells Fargo & Co | 462.84K | 192.19K | 195.89K | 138.51K | 139.65K | 136.66K | 206.59K | 200.44K | 203.24K | 168.40K | 216.39K | 227.60K | 203.03K | 220.12K | 265.53K | 235.84K | 303.28K | 318.98K | 280.71K | 263.17K |
| Citigroup Inc | 28.51K | 30.79K | 30.38K | 91.25K | 206.59K | 204.95K | 251.01K | 108.49K | 112.11K | 111.08K | 101.47K | 38.10K | 24.42K | 151.16K | 260.65K | 215.09K | 60.49K | 132.69K | 100.97K | 216.32K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details